Welcome to SAfAIDS
2016 has fast come and gone! We are now in December, the last month of 2016. As in past years, the 1st of December is a day when the whole world commemorates World AIDS Day. SAfAIDS joins the rest of the world today in standing together and walking the Ending AIDS by 2030 journey with zest. This is the day that we need to raise awareness about HIV and demonstrate our commitment and solidarity to all efforts being done in the global HIV response.
SAfAIDS Media Desk, 17 October 2016 (SAfAIDS) - Against the backdrop of many reported cases of teenage pregnancies and abortion, Positive Talk Live chat put up the issue for discussion to bring to light why this trend is increasing at an alarming rate. The discussion aimed to bring out the issues of responsibilities and choices made by young people and the risks associated with indulging in sexual activity.
SAfAIDS in partnership with Khulisa Umntfwana successfully conducted a 2-day training for 30 traditional leaders at ESibayeni Lodge in October 2016. The Traditional Leaders came from 15 chiefdoms in the four regions of Swaziland. SAfAIDS Deputy Director, Khulisa Umntfwana Executive Director and two National Technical Advisory Committee (NTAC) members also participated the training.
LONDON, 11 November 2016 (AVERT) - Viral load testing may become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.
GENEVA, 11 November 2016 (UNAIDS) - Around 180 young women and adolescent girls from Malawi, Kenya and Uganda have led a pilot project that aims to strengthen the leadership of young women and adolescent girls in the AIDS response.
Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV
LONDON, 10 November 2016 (aidsmap) - A co-formulation of tenofovir alafenamide (TAF) plus emtricitabine, used with a third antiretroviral drug, maintained viral suppression as well as tenofovir disoproxil fumarate (TDF) plus emtricitabine in older individuals, and was associated with improvements in kidney function and bone density, which may be of greater concern for this group, according to a presentation last week at IDWeek 2016 in New Orleans.